Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...
President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...
MET-3 is under clinical development by Nubiyota and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II drugs for Hypertriglyceridemia have a 52% phase transition success ...
PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...
Climate transition, geopolitical dynamics, and technological advancement continue to reshape the investment landscape. Taking ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Even before Trump enters the White House, the planet is showing worrying vital signs with scientists virtually certain 2024 ...